These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 23933333)

  • 1. Peptide nanofiber hydrogel adjuvanted live virus vaccine enhances cross-protective immunity to porcine reproductive and respiratory syndrome virus.
    Li X; Galliher-Beckley A; Huang H; Sun X; Shi J
    Vaccine; 2013 Sep; 31(41):4508-15. PubMed ID: 23933333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune responses and protection by vaccine and various vaccine adjuvant candidates to virulent porcine reproductive and respiratory syndrome virus.
    Charerntantanakul W; Platt R; Johnson W; Roof M; Vaughn E; Roth JA
    Vet Immunol Immunopathol; 2006 Jan; 109(1-2):99-115. PubMed ID: 16165219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-protective immunity to porcine reproductive and respiratory syndrome virus by intranasal delivery of a live virus vaccine with a potent adjuvant.
    Dwivedi V; Manickam C; Patterson R; Dodson K; Murtaugh M; Torrelles JB; Schlesinger LS; Renukaradhya GJ
    Vaccine; 2011 May; 29(23):4058-66. PubMed ID: 21419162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant Porcine Reproductive and Respiratory Syndrome Virus Expressing Membrane-Bound Interleukin-15 as an Immunomodulatory Adjuvant Enhances NK and γδ T Cell Responses and Confers Heterologous Protection.
    Cao QM; Ni YY; Cao D; Tian D; Yugo DM; Heffron CL; Overend C; Subramaniam S; Rogers AJ; Catanzaro N; LeRoith T; Roberts PC; Meng XJ
    J Virol; 2018 Jul; 92(13):. PubMed ID: 29643245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-mediated immune response and protective efficacy of porcine reproductive and respiratory syndrome virus modified-live vaccines against co-challenge with PRRSV-1 and PRRSV-2.
    Madapong A; Saeng-Chuto K; Boonsoongnern A; Tantituvanont A; Nilubol D
    Sci Rep; 2020 Feb; 10(1):1649. PubMed ID: 32015495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune response and protective efficacy of intramuscular and intradermal vaccination with porcine reproductive and respiratory syndrome virus 1 (PRRSV-1) modified live vaccine against highly pathogenic PRRSV-2 (HP-PRRSV-2) challenge, either alone or in combination with of PRRSV-1.
    Madapong A; Saeng-Chuto K; Chaikhumwang P; Tantituvanont A; Saardrak K; Pedrazuela Sanz R; Miranda Alvarez J; Nilubol D
    Vet Microbiol; 2020 May; 244():108655. PubMed ID: 32402335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positive inductive effect of swine interleukin-4 on immune responses elicited by modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine.
    Peng J; Wang J; Wu J; Du Y; Li J; Guo Z; Yu J; Xu S; Zhang Y; Sun W; Cong X; Shi J
    Viral Immunol; 2013 Dec; 26(6):404-14. PubMed ID: 24328935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of simultaneous vaccination with two modified live virus vaccines against porcine reproductive and respiratory syndrome virus types 1 and 2 in pigs.
    Kristensen CS; Kvisgaard LK; Pawlowski M; Holmgaard Carlsen S; Hjulsager CK; Heegaard PMH; Bøtner A; Stadejek T; Haugegaard S; Larsen LE
    Vaccine; 2018 Jan; 36(2):227-236. PubMed ID: 29191738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative analysis of routes of immunization of a live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine in a heterologous virus challenge study.
    Ouyang K; Hiremath J; Binjawadagi B; Shyu DL; Dhakal S; Arcos J; Schleappi R; Holman L; Roof M; Torrelles JB; Renukaradhya GJ
    Vet Res; 2016 Mar; 47():45. PubMed ID: 26988085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of PRRSV-2 MLV vaccines administrated via the intramuscular or intradermal route and evaluation of PRRSV transmission upon needle-free and needle delivery.
    Madapong A; Saeng-Chuto K; Tantituvanont A; Nilubol D
    Sci Rep; 2021 Nov; 11(1):23107. PubMed ID: 34845289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of commercial modified-live PRRSV-1 and PRRSV-2 vaccines against a dual heterologous PRRSV-1 and PRRSV-2 challenge in late term pregnancy gilts.
    Yang S; Oh T; Cho H; Chae C
    Comp Immunol Microbiol Infect Dis; 2020 Apr; 69():101423. PubMed ID: 31972500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of a modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine in pigs naturally exposed to a heterologous European (Italian cluster) field strain: Clinical protection and cell-mediated immunity.
    Martelli P; Gozio S; Ferrari L; Rosina S; De Angelis E; Quintavalla C; Bottarelli E; Borghetti P
    Vaccine; 2009 Jun; 27(28):3788-99. PubMed ID: 19442420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a broadly protective modified-live virus vaccine candidate against porcine reproductive and respiratory syndrome virus.
    Sun H; Workman A; Osorio FA; Steffen D; Vu HLX
    Vaccine; 2018 Jan; 36(1):66-73. PubMed ID: 29174314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A porcine reproductive and respiratory syndrome virus candidate vaccine based on the synthetic attenuated virus engineering approach is attenuated and effective in protecting against homologous virus challenge.
    Evenson D; Gerber PF; Xiao CT; Halbur PG; Wang C; Tian D; Ni YY; Meng XJ; Opriessnig T
    Vaccine; 2016 Nov; 34(46):5546-5553. PubMed ID: 27742217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative evaluation of 4 commercial modified-live porcine reproductive and respiratory syndrome virus (PRRSV) vaccines against heterologous dual Korean PRRSV-1 and PRRSV-2 challenge.
    Oh T; Park SJ; Cho H; Yang S; Ham HJ; Chae C
    Vet Med Sci; 2020 Nov; 6(4):846-853. PubMed ID: 32437071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of four commercial PRRSV MLV vaccines in herds with co-circulation of PRRSV-1 and PRRSV-2.
    Oh T; Kim H; Park KH; Jeong J; Yang S; Kang I; Chae C
    Comp Immunol Microbiol Infect Dis; 2019 Apr; 63():66-73. PubMed ID: 30961820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-protection of a modified-live porcine reproductive and respiratory syndrome virus (PRRSV)-2 vaccine against a heterologous PRRSV-1 challenge in late-term pregnancy gilts.
    Jeong J; Park C; Oh T; Park KH; Yang S; Kang I; Park SJ; Chae C
    Vet Microbiol; 2018 Sep; 223():119-125. PubMed ID: 30173737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of two genetically distant type 2 porcine reproductive and respiratory syndrome virus (PRRSV) modified live vaccines against Vietnamese highly pathogenic PRRSV.
    Do DT; Park C; Choi K; Jeong J; Nguyen TT; Nguyen KD; Vo DT; Chae C
    Vet Microbiol; 2015 Sep; 179(3-4):233-41. PubMed ID: 26149103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A DNA Prime Immuno-Potentiates a Modified Live Vaccine against the Porcine Reproductive and Respiratory Syndrome Virus but Does Not Improve Heterologous Protection.
    Bernelin-Cottet C; Urien C; Fretaud M; Langevin C; Trus I; Jouneau L; Blanc F; Leplat JJ; Barc C; Boulesteix O; Riou M; Dysart M; Mahé S; Studsrub E; Nauwynck H; Bertho N; Bourry O; Schwartz-Cornil I
    Viruses; 2019 Jun; 11(6):. PubMed ID: 31242645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-administration of saponin quil A and PRRSV-1 modified-live virus vaccine up-regulates gene expression of type I interferon-regulated gene, type I and II interferon, and inflammatory cytokines and reduces viremia in response to PRRSV-2 challenge.
    Charerntantanakul W; Pongjaroenkit S
    Vet Immunol Immunopathol; 2018 Nov; 205():24-34. PubMed ID: 30458999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.